These findings provided an improved understanding of the molecular mechanisms of estrogen-dependent endometrial carcinoma, and might instruct to screen the targets for hormone-dependent gynecologic tumors related to HER-2/neu. Here, ERBB2 is linked to endometrial carcinoma.